...
首页> 外文期刊>Fundamental & clinical pharmacology. >Involvement of α2-adrenoceptors, imidazoline, and endothelin-A receptors in the effect of agmatine on morphine and oxycodone-induced hypothermia in mice
【24h】

Involvement of α2-adrenoceptors, imidazoline, and endothelin-A receptors in the effect of agmatine on morphine and oxycodone-induced hypothermia in mice

机译:α2-肾上腺素受体,咪唑啉和内皮素-A受体参与胍丁胺对小鼠吗啡和羟考酮诱导的体温过低的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Potentiation of opioid analgesia by endothelin-A (ETA) receptor antagonist, BMS182874, and imidazoline receptor/α2-adrenoceptor agonists such as clonidine and agmatine are well known. It is also known that agmatine blocks morphine hyperthermia in rats. However, the effect of agmatine on morphine or oxycodone hypothermia in mice is unknown. The present study was carried out to study the role of α2-adrenoceptors, imidazoline, and ETA receptors in morphine and oxycodone hypothermia in mice. Body temperature was determined over 6 h in male Swiss Webster mice treated with morphine, oxycodone, agmatine, and combination of agmatine with morphine or oxycodone. Yohimbine, idazoxan, and BMS182874 were used to determine involvement of α2-adrenoceptors, imidazoline, and ETA receptors, respectively. Morphine and oxycodone produced significant hypothermia that was not affected by α2-adrenoceptor antagonist yohimbine, imidazoline receptor/α2 adrenoceptor antagonist idazoxan, or ETA receptor antagonist, BMS182874. Agmatine did not produce hypothermia; however, it blocked oxycodone but not morphine-induced hypothermia. Agmatine-induced blockade of oxycodone hypothermia was inhibited by idazoxan and yohimbine. The blockade by idazoxan was more pronounced compared with yohimbine. Combined administration of BMS182874 and agmatine did not produce changes in body temperature in mice. However, when BMS182874 was administered along with agmatine and oxycodone, it blocked agmatine-induced reversal of oxycodone hypothermia. This is the first report demonstrating that agmatine does not affect morphine hypothermia in mice, but reverses oxycodone hypothermia. Imidazoline receptors and α2-adrenoceptors are involved in agmatine-induced reversal of oxycodone hypothermia. Our findings also suggest that ETA receptors may be involved in blockade of oxycodone hypothermia by agmatine.
机译:内皮素-A(ETA)受体拮抗剂BMS182874和咪唑啉受体/α2-肾上腺素受体激动剂(如可乐定和胍丁胺)可增强阿片类药物的镇痛作用。还已知胍丁胺阻断大鼠吗啡热疗。但是,胍丁胺对小鼠吗啡或羟考酮低温的作用尚不清楚。本研究旨在研究α2-肾上腺素能受体,咪唑啉和ETA受体在小鼠吗啡和羟考酮低温中的作用。在用吗啡,羟考酮,胍丁胺以及胍丁胺与吗啡或羟考酮的组合治疗的雄性Swiss Webster小鼠中,测定体温超过6小时。育亨宾,伊达唑烷和BMS182874分别用于确定α2-肾上腺素能受体,咪唑啉和ETA受体的参与。吗啡和羟考酮产生的体温过低,不受α2-肾上腺素受体拮抗剂育亨宾,咪唑啉受体/α2肾上腺素受体拮抗剂伊达唑烷或ETA受体拮抗剂BMS182874的影响。胍丁胺不产生体温过低;然而,它阻止了羟考酮,但没有阻止吗啡引起的体温过低。胍丁胺和育亨宾可抑制胍丁胺诱导的羟考酮低温治疗。与育亨宾相比,伊达唑烷的阻断作用更为明显。 BMS182874和胍丁胺的联合给药不会在小鼠体内产生体温变化。但是,当BMS182874与胍丁胺和羟考酮同时给药时,它会阻止胍丁胺引起的羟考酮低温逆转。这是首次证明胍丁胺不影响小鼠吗啡低温,但逆转了羟考酮低温。咪唑啉受体和α2-肾上腺素受体参与胍丁胺诱导的羟考酮低温治疗的逆转。我们的发现还表明,ETA受体可能参与了胍丁胺对羟考酮低温的阻断作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号